Clopidogrel is used as a frontline antiplatelet drug in patients with coronary artery disease, peri-pheral vascular disease and cerebrovascular disease. Though it is frequently reported that clopi-dogrel is associated with thrombotic thrombocytopenic purpura (TTP), severe isolated thrombo-cytopenia induced by this drug is rare. Here we report a case with isolated thrombocytopenia due to clopidogrel therapy. As this agent is widely used in clinical practice, the occurrence of this rare but dangerous adverse effect should be considered
With the advent of medical technology, coronary angiography is a common practice to evaluate patient...
Clopidogrel is a second generation of thienopyridine, which has antiplatelet effect by inhibiting P2...
Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of pat...
Clopidogrel is a new oral antiplatelet agent with structure and mechanism of action similar to ticlo...
Clopidogrel is a new oral antiplatelet agent with a structure and mechanism of action similar to tic...
Clopidogrel – a popular antiplatelet drug widely used in treatment of various vascular disease...
We report a case of moderate thrombocytopenia associated with purpura-like phenomenon (four ecchymos...
Introduction In 1991, Page and colleagues published a report of four cases of thrombotic thrombocyto...
INTRODUCTION: Clopidogrel is frequently associated with thrombotic thrombocytopenic purpura, however...
BACKGROUND: The antiplatelet drug clopidogrel is a new thienopyridine derivative whose mechanism of ...
We present the case of an 84-year-old female patient admitted to the Internal Medicine Ward for atyp...
Hepatotoxicity is a rare adverse reaction to clopi-dogrel that can evolve to fulminant hepatitis if ...
Clopidogrel is an irreversible antiplatelet agent belonging to the thienopyridine group that acts to...
Thrombotic thrombocytopenic purpura (TTP) is a rare multisystem disease, characterized by thrombocyt...
Clopidogrel has been reported to be safe and effective in reducing vascular events. Nevertheless, th...
With the advent of medical technology, coronary angiography is a common practice to evaluate patient...
Clopidogrel is a second generation of thienopyridine, which has antiplatelet effect by inhibiting P2...
Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of pat...
Clopidogrel is a new oral antiplatelet agent with structure and mechanism of action similar to ticlo...
Clopidogrel is a new oral antiplatelet agent with a structure and mechanism of action similar to tic...
Clopidogrel – a popular antiplatelet drug widely used in treatment of various vascular disease...
We report a case of moderate thrombocytopenia associated with purpura-like phenomenon (four ecchymos...
Introduction In 1991, Page and colleagues published a report of four cases of thrombotic thrombocyto...
INTRODUCTION: Clopidogrel is frequently associated with thrombotic thrombocytopenic purpura, however...
BACKGROUND: The antiplatelet drug clopidogrel is a new thienopyridine derivative whose mechanism of ...
We present the case of an 84-year-old female patient admitted to the Internal Medicine Ward for atyp...
Hepatotoxicity is a rare adverse reaction to clopi-dogrel that can evolve to fulminant hepatitis if ...
Clopidogrel is an irreversible antiplatelet agent belonging to the thienopyridine group that acts to...
Thrombotic thrombocytopenic purpura (TTP) is a rare multisystem disease, characterized by thrombocyt...
Clopidogrel has been reported to be safe and effective in reducing vascular events. Nevertheless, th...
With the advent of medical technology, coronary angiography is a common practice to evaluate patient...
Clopidogrel is a second generation of thienopyridine, which has antiplatelet effect by inhibiting P2...
Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of pat...